SUVEN

Suven Life Sciences Limited

Source: NSE · Updated 5 Nov, 10:00 pm IST

Filed 5 Nov, 01:29 pm IST Q2 FY27 (Sep ’26)Consolidated₹ lakhs

Revenue

119.86

▲ 30.4% vs Q2 FY26

Operating profit (EBITDA, derived from filing)

-11,091.66

vs Q2 FY26: n/a

Net profit

-10,694.21

vs Q2 FY26: n/a

EPS (₹)

-3.77

vs Q2 FY26: n/a

Operating margin

-9253.8%

−57550 bps vs Q2 FY26

Net margin

-8922.3%

−51170 bps vs Q2 FY26

Loss widened vs Q2 FY26

Revenue+30% vs Q2 FY26 · −66% vs Q1 FY27

ProfitLoss widened vs Q2 FY26 · Loss narrowed vs Q1 FY27

View official filing ↗

Numbers from the company's structured XBRL filing on NSE, cross-checked with P&L totals and the filing PDF.

Quarter comparison

Item	Q2 FY27 (Sep ’26)	Q1 FY27 (Jun ’26)	vs Q1 FY27	Q2 FY26 (Sep ’25)	vs Q2 FY26
Revenue from operations	119.86	356.58	▼ 66.4%	91.92	▲ 30.4%
Other income	673.44	752.36	▼ 10.5%	377.8	▲ 78.3%
Total income	793.3	1,108.94	▼ 28.5%	469.72	▲ 68.9%
Total expenses	11,487.51	13,869.97	▼ 17.2%	8,200.71	▲ 40.1%
Operating profit (EBITDA)*	-11,091.66	-13,250.27	—	-7,977.11	—
Profit before tax	-10,694.21	-12,761.03	—	-7,730.99	—
Net profit	-10,694.21	-12,761.03	—	-7,730.99	—
EPS (₹)	-3.77	-4.84	—	-3.48	—
Operating margin	-9253.8%	-3715.9%	−553790 bps	-8678.3%	−57550 bps
Net margin	-8922.3%	-3578.7%	−534360 bps	-8410.6%	−51170 bps

Showing Q2 FY27 (Sep ’26) and change vs Q2 FY26. Turn your phone sideways for Q1 FY27 (Jun ’26).

Figures in ₹ lakhs except EPS. Consolidated figures from the company's XBRL filing on NSE. Each row is shown only if it reconciles with the others (e.g. PBT − tax = net profit); rows we couldn't verify are left out. Net margin = net profit ÷ revenue. *Operating profit (EBITDA), derived from the filing: profit before exceptional items and tax + finance costs + depreciation − other income. Operating margin = EBITDA ÷ revenue.

All Suven Life Sciences results, dividends & filings ›

Other results filed 5 Nov

NIMBSPROJ Nimbus Projects Limited›IKS Inventurus Knowledge Solutions Limited›ASHOKA Ashoka Buildcon Limited›POWERICA Powerica Limited›DBREALTY Valor Estate Limited›GOKEX Gokaldas Exports Limited›LEMONTREE Lemon Tree Hotels Limited›TIMETECHNO Time Technoplast Limited›BAGFILMS B.A.G Films and Media Limited›MUTHOOTCAP Muthoot Capital Services Limited›ARMEE ArMee Infotech Limited›MMFL MM Forgings Limited›

Today's results ›

SUVEN LIFE SCIENCES Q2 FY27 ; NET LOSS OF ₹107 CR VS LOSS ₹77 CR (YOY), LOSS ₹128 CR (QOQ)

REVENUE UP 30% AT ₹1.20 CR (YOY), DOWN 66% (QOQ)

EBITDA LOSS OF ₹111 CR VS LOSS ₹80 CR (YOY), LOSS ₹133 CR (QOQ)

MARGINS AT -9253.8% VS -8678.3% (YOY), -3715.9% (QOQ)

https://resultkal.com/r/suven-2026-11-05
Source: NSE filing · not investment advice

FAQ

When did Suven Life Sciences announce Q2 FY27 results?

Suven Life Sciences filed its results on NSE on 5 Nov, 01:29 pm IST.

What does QoQ and YoY mean?

QoQ compares with the previous quarter; YoY compares with the same quarter last year. Growth is calculated from the figures in the filing.

Are these Suven Life Sciences figures official?

They are auto-read from the company's NSE filing and may contain errors. Always confirm with the official PDF linked on this page.

Explore

Today's results Results this week Q2 FY27 results dates Dividend stocks this week Bonus issue 2026 Stock split 2026

Figures are auto-read from the company's NSE filing and may contain errors. Check the official filing before deciding. Not investment advice.

← SUVEN overview